Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Changes of Energetic Substrates on Myocardial Function and Metabolism in Chronic Heart Failure (ACITRIM)
2007-000763-18Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acipimox and trimetazidine in chronic heart failure (CHF), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Change in cardiac metabolism and energetic substrate preference. Started Apr 2007; status: completed.
02
Drugs
acipimoxtrimetazidine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2007-000763-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000763-18.